Medical Group Wants Justices To Review IP Safe Harbor Fight

By Adam Lidgett · November 18, 2024, 5:51 PM EST

A medical device trade group has said the U.S. Supreme Court should take up an appeal of a Federal Circuit decision Edwards Lifesciences said broadened a drug-development safe harbor to avoid...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Edwards Lifesciences Corporation, et al., Petitioners v. Meril Life Sciences Pvt. Ltd., et al.

Case Number

Court

Supreme Court

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

October 16, 2024

Recent Articles By Adam

December 12, 2024
Medicare Could Lose Billions From 'Patent Abuse,' Group Says
December 09, 2024
High Court Won't Hear Zimmer Biomet Royalties Fight
November 01, 2024
Jury To Decide Timing Issue In Insulin Patch Trade Secret Row
October 22, 2024
Patent Office Finds Public Engagement Leader
September 23, 2024
Fed. Circ. OKs Novartis Loss In Eye Syringe Patent Feud
July 11, 2024
Senate Clears Patent Bill Aiming To Lower Drug Prices
June 07, 2024
DC Circ. Undoes Library Of Congress Win In Fair Use Fight
June 06, 2024
8th Circ. Affirms Cigna Noncompete Applies To CVS Hire
May 29, 2024
Greenberg Traurig Adds IP Atty From Eversheds Sutherland
May 20, 2024
Judge Tosses Acuitas' COVID Biotech IP Suit